3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Not yet recruiting
1
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
26
Prostatic Neoplasms
24
Brain Neoplasms
21
Neoplasms
13
Glioma
10
Head and Neck Neoplasms
8
Pancreatic Neoplasms
7
Glioblastoma
6
Lung Neoplasms
5
Colonic Neoplasms
5
Carcinoma, Hepatocellular
5
Astrocytoma
5
Uterine Cervical Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Rectal Neoplasms
4
Lymphoma
4
Central Nervous System Neoplasms
4
Urinary Bladder Neoplasms
3
Triple Negative Breast Neoplasms
3
Spinal Cord Neoplasms
3
Sarcoma
3
Liver Neoplasms
3
Disease
3
Retinoblastoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pathologic Complete Response
2
Oligodendroglioma
2
Neurofibromatosis 1
2
Meningioma
2
Lymphoma, Non-Hodgkin
2
Interventions
Carboplatin
5
pembrolizumab
4
Trastuzumab
4
Oxaliplatin
4
Fluorouracil
4
Cyclophosphamide
4
Radiotherapy
3
Paclitaxel
3
Endoscopy
3
Docetaxel
3
Cytarabine
3
Chemoradiotherapy
3
Capecitabine
3
toripalimab
2
Tretinoin
2
Surgical Procedures, Operative
2
Standard of Care
2
Observation
2
Neoadjuvant Therapy
2
Metformin
2
Magnetic Resonance Imaging
2
Leucovorin
2
Irinotecan
2
Immunotherapy
2
Immune Checkpoint Inhibitors
2
Epirubicin
2
Drug Therapy
2
Doxorubicin
2
Cisplatin
2
Blood Specimen Collection
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER
×
Pathologic Complete Response
×
Magnetic Resonance Imaging
×
Clear all
NCT07472868
2026-03-16
MEND-IT II
Catharina Ziekenhuis Eindhoven
Phase 3
Not yet recruiting
394 enrolled
NCT03474341
2020-11-16
PRIDE
UMC Utrecht
Unknown
200 enrolled